TARSUS PHARMACEUTICALS, INC. (TARS) Operating income 2019–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual operating income history from SEC filings — each fiscal year as reported.
-$71.0MFY2025 · since FY2019: -$4.3M → -$71.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$71.0M | +41.1% |
| FY2024 | -$120.6M | +15.8% |
| FY2023 | -$143.2M | -128.3% |
| FY2022 | -$62.7M | -415.9% |
| FY2021 | -$12.2M | +55.0% |
| FY2020 | -$27.0M | -528.2% |
| FY2019 | -$4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice